Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in the human eye. The study, called ER-100, uses a gene therapy vector to ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy designed to reverse cellular aging in the human eye. The trial, registered as ...
The world's first anti-ageing gene therapy has just been injected into a human - here's what it does
First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have treated the first participant in a clinical trial exploring whether older cells ...
Zhou’s study, "TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming," was recently published in Circulation. The most common cause of death worldwide is ...
The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results